XOMA Royalty Corporation (XOMA)
NASDAQ: XOMA · Real-Time Price · USD
40.86
-1.11 (-2.64%)
Apr 28, 2026, 4:00 PM EDT - Market closed
XOMA Royalty Employees
XOMA Royalty had 14 employees as of December 31, 2025. The number of employees increased by 1 or 7.69% compared to the previous year.
Employees
14
Change (1Y)
1
Growth (1Y)
7.69%
Revenue / Employee
$3,724,929
Profits / Employee
$1,322,571
Market Cap
486.88M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Valneva SE | 674 |
| 4D Molecular Therapeutics | 196 |
| ADC Therapeutics | 193 |
| Verastem | 102 |
| Upstream Bio | 75 |
| Fulcrum Therapeutics | 55 |
| Candel Therapeutics | 55 |
XOMA News
- 1 day ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of XOMA Royalty Corporation - PRNewsWire
- 1 day ago - Ligand Bets On Royalty Growth With XOMA Buyout Worth Over $700 Million - Benzinga
- 1 day ago - Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand's Position as a Leading Biopharma Royalty Aggregator - GlobeNewsWire
- 5 weeks ago - XOMA Royalty Declares Quarterly Preferred Stock Dividends - GlobeNewsWire
- 5 weeks ago - XOMA Royalty Jumps After Q4 Double Beat, Signals Pipeline Catalysts Ahead - Benzinga
- 5 weeks ago - XOMA Royalty Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements - GlobeNewsWire
- 6 weeks ago - XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026 - GlobeNewsWire